LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 36.01 | 27.76 | 1112 | 2662 | 0.4176 | 0.7516 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 36.01 | 27.76 | 1202 | 2662 | 0.4514 | 0.7724 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 36.01 | 27.76 | 1275 | 2662 | 0.4788 | 0.7883 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 36.01 | 27.76 | 1375 | 2662 | 0.5164 | 0.8090 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 37.71 | 27.76 | 1152 | 2877 | 0.4003 | 0.7444 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 37.71 | 27.76 | 1243 | 2877 | 0.4320 | 0.7643 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 37.71 | 27.76 | 1306 | 2877 | 0.4538 | 0.7774 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 37.71 | 27.76 | 1394 | 2877 | 0.4844 | 0.7948 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 39.41 | 27.76 | 1174 | 3105 | 0.3780 | 0.7336 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 39.41 | 27.76 | 1259 | 3105 | 0.4054 | 0.7515 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 39.41 | 27.76 | 1358 | 3105 | 0.4373 | 0.7711 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 39.41 | 27.76 | 1451 | 3105 | 0.4672 | 0.7884 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 41.11 | 27.76 | 1237 | 3331 | 0.3713 | 0.7328 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 41.11 | 27.76 | 1320 | 3331 | 0.3962 | 0.7491 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 41.11 | 27.76 | 1386 | 3331 | 0.4160 | 0.7615 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 41.11 | 27.76 | 1509 | 3331 | 0.4530 | 0.7833 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 42.81 | 27.76 | 1263 | 3596 | 0.3512 | 0.7229 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 42.81 | 27.76 | 1353 | 3596 | 0.3762 | 0.7399 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 42.81 | 27.76 | 1439 | 3596 | 0.4001 | 0.7553 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 42.81 | 27.76 | 1524 | 3596 | 0.4238 | 0.7697 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 44.52 | 27.76 | 1270 | 3884 | 0.3270 | 0.7097 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 44.52 | 27.76 | 1370 | 3884 | 0.3527 | 0.7280 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 44.52 | 27.76 | 1461 | 3884 | 0.3761 | 0.7437 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 44.52 | 27.76 | 1568 | 3884 | 0.4037 | 0.7610 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 46.22 | 27.76 | 1243 | 4125 | 0.3013 | 0.6937 | MN20160318_Q01 | E05 |